A comparative audit of anticardiolipin antibodies in oligoclonal band negative and positive multiple sclerosis

Multiple Sclerosis

Volumn 11, Issue 4, 2005, Pages 378-380

  Vilisaar, Janek ^a   Wilson, Martin ^b   Niepel, Graham ^b   Blumhardt, Lance D ^b   Constantinescu, Cris S ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antibodies; Anticardiolipin; Antiphospholipid syndrome; Autoantibodies; Lupus anticoagulant; Multiple sclerosis; Oligoclonal bands

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; BIOCHEMICAL MARKER; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; OLIGOCLONAL BAND;

ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISABILITY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FREQUENCY ANALYSIS; HUMAN; IMMUNE DEFICIENCY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIPLE SCLEROSIS; RATING SCALE; SCORING SYSTEM; SEX DIFFERENCE; SYMPTOMATOLOGY;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 22144465185     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1208oa     Document Type: Article

References (10)

1. Karussis D, Leker RR, Ashkenazi A, Abramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998; 44: 629-34.
2. Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, Tashiro K. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 1993; 88: 184-89.
3. Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine 2000; 79: 57-68.
4. Chapman J, Rand JH, Brey RL, Levine SR, Blatt I, Khamashta MA, et al. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus 2003; 12: 514-17.
5. Cohen JA, Rensel MR. The differential diagnosis and clues to misdiagnosis. In Burks J and Johnson KP, editors. Multiple Sclerosis. New York: Demos Medical Publishers, 2000: 127-141.
6. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557-65.
7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
8. Poser C, Paty D, Scheinberg L, McDonald W, Davis F, Ebers G, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
9. Keir G, Luxton RW, Thompson EJ. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update. Ann Clin Biochem 1990; 27: 436-43.
10. Zeman AZ, Kidd D, McLean BN, Kelly MA, Francis DA, Miller DH, et al. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psych 1996; 60: 27-30.